Burosumab-twza Price in India: What Determines the Overall Treatment Cost?
Buy burosumab-twza injection in India For patients and families managing rare disorders such as X-linked hypophosphatemia (XLH) or tumor-induced osteomalacia (TIO), the cost of treatment can be an important consideration. Burosumab-twza, marketed as Crysvita, is a targeted therapy designed to address the underlying FGF23-driven phosphate imbalance associated with these conditions. However, there is no single fixed burosumab-twza price in India that applies to every patient. The overall amount depends on several factors, including the prescribed dose, treatment frequency, international sourcing, import-related expenses, taxes, documentation, shipping and currency exchange rates. What is Burosumab-twza? Burosumab-twza is a recombinant human monoclonal IgG1 antibody that targets and inhibits fibroblast growth factor 23 (FGF23). By inhibiting excess FGF23, it helps restore phosphate balance and support bone health. Crysvita is supplied as a subcutaneous injection in single-dose vials avai...